Phase i study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors

Chia Chi Lin, Emiliano Calvo, Kyriakos P. Papadopoulos, Amita Patnaik, John Sarantopoulos, Alain C. Mita, Glenn G. Preston, Monica M. Mita, Jordi Rodon, Theresa Mays, I. Tien Yeh, Pat O'Rourke, Chris H. Takimoto, Janet E. Dancey, Helen Chen, Anthony W. Tolcher

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Neuroscience

Agricultural and Biological Sciences